𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of ABT-874, a monoclonal anti–interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial

✍ Scribed by Alexa B. Kimball; Kenneth B. Gordon; Richard G. Langley; Alan Menter; Renee J. Perdok; Joaquin Valdes


Book ID
116586716
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
620 KB
Volume
64
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES